» Articles » PMID: 39524915

Global Burden of Multiple Sclerosis and Its Attributable Risk Factors, 1990-2019

Overview
Journal Front Neurol
Specialty Neurology
Date 2024 Nov 11
PMID 39524915
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple sclerosis (MS) is a progressively debilitating disorder that has seen a notable rise in prevalence in recent years. This study examines the burden of MS from 1990 to 2019, providing a detailed analysis by age, sex, and sociodemographic index (SDI) across 204 countries and territories.

Methods: Data on the prevalence, death and disability-adjusted life years (DALYs) attributable to MS were obtained from the publically available Global Burden of Disease 2019 project. The estimates are reported as numbers, percentages, and age-standardized rates per 100,000, accompanied by 95% uncertainty intervals.

Results: In 2019, MS accounted for 1.8 million prevalent cases, 22.4 thousand deaths and 1.2 million DALYs worldwide. There were significant declines in the global age-standardized prevalence, mortality and DALY rates of MS over the period 1990-2019. In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. At the regional level, a non-linear relationship was observed between the age-standardized DALY rate of MS and SDI.

Conclusion: Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. Integrating MS and its associated risk factors into healthcare planning is vital, especially in areas with high levels of socioeconomic development.

Citing Articles

Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery.

Almheiri R, Hajjar B, Alkhaaldi S, Rabeh N, Aljoudi S, Abd-Elrahman K J Transl Med. 2025; 23(1):223.

PMID: 39994634 PMC: 11852891. DOI: 10.1186/s12967-025-06201-2.

References
1.
Qian Z, Li Y, Guan Z, Guo P, Zheng K, Du Y . Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019. Front Public Health. 2023; 11:1073278. PMC: 9982151. DOI: 10.3389/fpubh.2023.1073278. View

2.
. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

3.
Voskuhl R, Gold S . Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol. 2012; 8(5):255-63. PMC: 4435786. DOI: 10.1038/nrneurol.2012.43. View

4.
Pedulla L, Santoyo-Medina C, Novotna K, Moumdjian L, Smedal T, Arntzen E . Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic. J Neurol Phys Ther. 2023; 47(2):112-121. DOI: 10.1097/NPT.0000000000000430. View

5.
DAmico E, Zanghi A, Serra A, Murabito P, Zappia M, Patti F . Management of dysphagia in multiple sclerosis: current best practice. Expert Rev Gastroenterol Hepatol. 2019; 13(1):47-54. DOI: 10.1080/17474124.2019.1544890. View